| 000 | 01744 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514042959.0 | ||
| 264 | 0 | _c20021203 | |
| 008 | 200212s 0 0 eng d | ||
| 022 | _a0146-6615 | ||
| 024 | 7 |
_a10.1002/jmv.10162 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBélec, Laurent | |
| 245 | 0 | 0 |
_aSustained high proportion of zidovudine-resistant HIV variants despite prolonged substitution of zidovudine by other nucleoside reverse transcriptase inhibitors. _h[electronic resource] |
| 260 |
_bJournal of medical virology _cSep 2002 |
||
| 300 |
_a1-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdaptation, Physiological _xgenetics |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xpharmacology |
| 650 | 0 | 4 |
_aDideoxynucleosides _xpharmacology |
| 650 | 0 | 4 | _aDrug Resistance, Viral |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHIV Seropositivity _xdrug therapy |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aZidovudine _xpharmacology |
| 700 | 1 | _aLegoff, Jérôme | |
| 700 | 1 | _aSi-Mohamed, Ali | |
| 700 | 1 | _aAndréoletti, Laurent | |
| 700 | 1 | _aMbopi-Kéou, François-Xavier | |
| 700 | 1 | _aKolberg, Janice | |
| 700 | 1 | _aMatta, Mathieu | |
| 700 | 1 | _aDetmer, Jill | |
| 700 | 1 | _aPiketty, Christophe | |
| 700 | 1 | _aKazatchkine, Michel D | |
| 773 | 0 |
_tJournal of medical virology _gvol. 68 _gno. 1 _gp. 1-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jmv.10162 _zAvailable from publisher's website |
| 999 |
_c12091246 _d12091246 |
||